Printed from the IBC Life Sciences Web site on May 18, 2013 0:36 PM ET.
Page location: http://www.ibclifesciences.com/Delivery/overview.xml
October 11-12, 2012 · Rhode Island Convention Center · Providence, RI
Co-Located with: IBC's Formulation Strategies for Protein Therapeutics - October 9-10, 2012.
Add one or two conference days to your registration to attend the Formulation sessions.
Register by June 22 and Save $500 off the standard rates
Deadline: September 7
» Submit your proposal
The Next Generation of Biotherapeutic Dosage Forms
Kevin R. King, Ph.D.,
Senior Director, Formulation & Process Development, Pfizer Inc.
Experiences in a QbD-Based FDA Regulatory Filing: Drug Product Considerations
Mary E.M. Cromwell, Ph.D.,
Director, Late Stage Pharmaceutical Development, Genentech, Inc.
The Next Generation of Biologics and the Role of Drug Delivery and Device Technologies
William J. Lambert, Ph.D.,
Fellow, Drug Delivery and Device Development, MedImmune, Inc.
Special Discounted Hotel Rate Available Until September 7, 2012.
To book your room, call 1-888-627-8449 and mention that you are an IBC attendee at this event.
Experience the networking opportunities of IBC's co-located BioProcess International Conference & Exhibition.
IBC's 12th Annual
Formulation Strategies for Protein Therapeutics
October 9-10, 2012
Delivery Strategies blends practical solutions related to the development of high dose drug products and drug/device combinations with forward looking information on novel delivery approaches for biotherapeutics.
Conference Sessions Explore the Emerging Science Behind Targeted Biologics Delivery and Next-Generation Routes of Administration:
The Formulation and Delivery conferences feature 25 Case Studies from these leading companies and much more: